Wolf's post-herpetic isotopic response to tocilizumab for rheumatoid arthritis

Australas J Dermatol. 2018 May;59(2):e135-e137. doi: 10.1111/ajd.12698. Epub 2017 Aug 9.

Abstract

Immediate and delayed hypersensitivity reactions may occur after the first or many exposures to tocilizumab, and they have varying presentations. Here, we describe a Wolf's isotopic response that manifested in a patient as erythema on the same site of a previous healed herpes zoster infection. This phenomenon has rarely been reported in the literature.

Keywords: TNF-α inhibitor; Wolf's isotopic response; hypersensitivity reaction; rash; rheumatoid arthritis; tocilizumab.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy
  • Drug Eruptions / etiology*
  • Erythema / etiology*
  • Female
  • Herpes Zoster / complications*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab